Sign up to get updates from us
In this episode, Marcus and Vic engage in a healthy debate surrounding the crucial question of the government's role in regulating AI as they dive into the complexities of balancing innovation and ethical considerations, exploring the potential risks...
In this episode, Marcus and Vic engage in a healthy debate surrounding the crucial question of the government's role in regulating AI as they dive into the complexities of balancing innovation and ethical considerations, exploring the potential risks and benefits associated with various regulatory approaches. They also discuss the latest developments in federal policies impacting the tech industry, analyze the dynamic landscape of venture markets, and examine the unprecedented pharmacist walk-out, shedding light on the underlying factors driving this bold act of protest. Tune in for a captivating exploration of these topics as we navigate the ever-evolving intersection of technology, governance, and societal impact.
Please check out our Episode Resources below:
------🔎RESOURCES🔎
Fed Extends Pause on Rate Hikes but Keeps Door Open to Moving Higher (WSJ) // https://bit.ly/3tZUHZb
Pharmacy staff from CVS, Walgreens stores in US start three-day walkout (Reuters) // https://bit.ly/40qzcwK
Another fallen ‘unicorn’: Olive AI sells assets, to wind down (Modern Healthcare) // https://bit.ly/40qznrU
State of Private Markets: Q3 2023 (Carta Research) // https://bit.ly/3tYDfEv
Biden Issues Executive Order on Safe, Secure, and Trustworthy AI (White House Fact Sheet) // https://bit.ly/40pxA6r
Google Brain cofounder says Big Tech is inflating fears about the risks of AI because they want to dominate the market( Business Insider) // https://bit.ly/3Ssk3Jl
2,851 Miles” Regulatory Capture Keynote Address by Bill Gurley Allin Summit // https://bit.ly/3QnKEVk
A glimpse of the next generation of AlphaFold (Google Deep Mind) // https://bit.ly/3u4TGza
